Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Biobank data showed.

2024 — Findings from a new USC Dornsife study suggest that when older adults fall for financial scams, it could be an early warning sign of Alzheimer's disease. Researchers used MRI scans to ...

To determine the diagnostic accuracy of the results of CSF tests compared to the gold standard PET imaging, the Munich researchers evaluated the data of over 400 patients with suspected Alzheimer's ...

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

The first drugs against Alzheimer's disease that are intended to slow down the progression of the condition will soon be authorized in Germany. On November 14, 2024, the EMA granted approval for ...

The FDA has approved BridgeBio’s acoramidis (Attruby), a transthyretin (TTR) stabilizer, for cardiac amyloidosis (ATTR-CM). It is the second drug to be approved for this heart disease ...

Vutrisiran, a transthyretin-directed small interfering RNA therapeutic, is currently approved under the brand name Amvuttra ® for the treatment of polyneuropathy manifestations of hereditary ...

The Food and Drug Administration (FDA) has approved Attruby TM (acoramidis) for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to ...

Here are four key findings: COVID-19 patients face an elevated risk of MACE, including heart attack, stroke and all-cause mortality, that persists for more than two years after infection.

In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a study being presented next week at the annual meeting of the Radiological ...

All new implants should be a fully MRI-compatible system. All new implants should at least be with MRI-compatible leads. No overwhelming need to implant an MRI-compatible device. Based on our ...